News
In the near term, commercial efforts might raise the chances that new patients are prescribed Novo Nordisk’s drug, assuming ...
Novo Nordisk ( NVO 1.82%) stock jumped 3% through 10:55 a.m. Tuesday on some potentially positive news in the GLP-1 weight ...
10d
TheJournal.ie on MSNMedicines and advertising regulators examine Ozempic maker's Irish adsIt’s illegal to advertise prescription drugs. Novo Nordisk, which makes Ozempic and Wegovy, has not named any drugs in its ...
Cigna’s pharmacy benefits unit Evernorth said the deal will bring prices down for employers and their workers.
Australia's central bank has cut interest rates to a two-year low as cooling inflation... Xeinadin, the professional services firm, has announced the acquisition of KBG Accountants... DUBLIN The Iseq ...
"The changes are made in light of the recent market challenges Novo Nordisk has been facing, and the development of the ...
5d
Al Jazeera on MSNIn surprise move Wegovy-maker Novo Nordisk ousts CEO amid sagging salesDays earlier, Novo Nordisk cut its sales and profit forecast for first time since the launch of Wegovy four years ago.
Novo Nordisk’s new top executive will need to help the company close the gap with Eli Lilly, fend off emerging rivals and ...
As its obesity medication Wegovy loses a sizable portion of the market to Eli Lilly and Company (NYSE:LLY)’s competing medicine, Zepbound, the Danish pharmaceutical behemoth Novo Nordisk A/S (NYSE:NVO ...
2d
GlobalData on MSNNovo Nordisk’s CEO to step down as weight loss market share plummetsNovo Nordisk is parting ways with its CEO Lars Fruergaard Jørgensen after the two parties mutually agreed that a change of ...
The Danish pharmaceutical giant said Fruergaard Jørgensen would remain in his post "for a period to support a smooth ...
Danish pharmaceutical company Novo Nordisk, maker of blockbuster weight loss drug Wegovy, said Friday its CEO was stepping ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results